TAREQ ABUASAB to Female
This is a "connection" page, showing publications TAREQ ABUASAB has written about Female.
Connection Strength
0.107
-
BRAF mutation in myeloid neoplasm: incidences and clinical outcomes. Leuk Lymphoma. 2024 09; 65(9):1344-1349.
Score: 0.032
-
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications. Am J Hematol. 2024 07; 99(7):1434-1436.
Score: 0.032
-
Review of Bleeding as Initial Presentation in Patients with Chronic Myeloid Leukemia. Clin Appl Thromb Hemost. 2026 Jan-Dec; 32:10760296261422761.
Score: 0.009
-
Clinical Outcomes and Patterns of Care Among Patients With Newly Diagnosed Classical Hodgkin Lymphoma in a Safety-Net Health System. Clin Lymphoma Myeloma Leuk. 2026 Jan; 26(1):e12-e20.e5.
Score: 0.009
-
Characteristics and outcomes of children, adolescent, and young adult patients with myelodysplastic neoplasms: A single-center retrospective analysis. Leuk Res. 2024 09; 144:107563.
Score: 0.008
-
Outcomes of Patients With Newly Diagnosed AML and Hyperleukocytosis. JCO Oncol Pract. 2024 Dec; 20(12):1637-1644.
Score: 0.008
-
Oral decitabine and cedazuridine plus venetoclax for older or unfit patients with acute myeloid leukaemia: a phase 2 study. Lancet Haematol. 2024 Apr; 11(4):e276-e286.
Score: 0.008